76 related articles for article (PubMed ID: 616125)
1. Effect of myasthenic immunoglobulin on ACh receptors of cultured muscle.
Drachman DB; Kao L; Angus CW; Murphy A
Trans Am Neurol Assoc; 1977; 102():96-100. PubMed ID: 616125
[No Abstract] [Full Text] [Related]
2. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
Mittag TW; Tormay A; Massa T
Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
[No Abstract] [Full Text] [Related]
3. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
Fontana A; Fulpius BW; Cuénoud S
Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
[No Abstract] [Full Text] [Related]
4. Reduction of acetylcholine sensitivity of chick muscle in culture by myasthenia gravis serum.
Harvey AL; Robertson JG; Barkas T; Harrison R; Lunt GG; Stephenson FA; Campbell MJ; Teague RH
Clin Exp Immunol; 1978 Dec; 34(3):411-6. PubMed ID: 743809
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
[No Abstract] [Full Text] [Related]
6. Interaction of foetal and adult human acetylcholine receptors with serum from patients with myasthenia gravis.
Lotwick H; Harrison R; Lunt G; Behan P
J Neuroimmunol; 1983 Jun; 4(3):167-74. PubMed ID: 6853696
[TBL] [Abstract][Full Text] [Related]
7. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
Vincent A; Solleveld HA
Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
[TBL] [Abstract][Full Text] [Related]
8. [Intrathecal immunoactivation in the patients with myasthenia gravis--autoantibodies in the cerebrospinal fluid].
Yamanaka N; Araki S
Rinsho Shinkeigaku; 1989 Jan; 29(1):13-7. PubMed ID: 2743683
[TBL] [Abstract][Full Text] [Related]
9. Antibody to acetylcholine receptors increases the turnover of acetylcholine receptor: clinical relevance and mechanism of action.
Clementi F; Conti Tronconi B; Fumagalli G; Pelloja F; Sher E; Sinigaglia F; Villa A
Ann Ist Super Sanita; 1982; 18(1):69-74. PubMed ID: 7171175
[No Abstract] [Full Text] [Related]
10. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.
Kao I; Drachman DB
Science; 1977 Apr; 196(4289):527-9. PubMed ID: 850793
[TBL] [Abstract][Full Text] [Related]
11. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
12. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
McAdams MW; Roses AD
Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
[TBL] [Abstract][Full Text] [Related]
13. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
Drachman DB; Angus CW; Adams RN; Kao I
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis immunoglobulin augments motor neuron survival without producing muscle paralysis.
Sohal GS; Leshner RT; Swift TR
Muscle Nerve; 1983 Feb; 6(2):122-7. PubMed ID: 6855796
[TBL] [Abstract][Full Text] [Related]
15. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
Lefvert AK
Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
[No Abstract] [Full Text] [Related]
16. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR
Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the nicotinic acetylcholine receptor, obtained from serum of myasthenic patients, may decrease acetylcholine release from rat hippocampal nerve endings in vitro.
Heilbronn E; Häggblad J; Kubát B
Ann N Y Acad Sci; 1981; 377():198-207. PubMed ID: 6951473
[TBL] [Abstract][Full Text] [Related]
18. The role of anti-acetylcholine receptor antibody in neonatal myasthenia gravis.
Skoglund RR; Roberts CC; Huddlestone J
Bull Los Angeles Neurol Soc; 1978; 43(2-4):66-9. PubMed ID: 757366
[TBL] [Abstract][Full Text] [Related]
19. Association of Km3 allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis.
Dondi E; Gajdos P; Bach JF; Garchon HJ
J Neuroimmunol; 1994 May; 51(2):221-4. PubMed ID: 8182118
[TBL] [Abstract][Full Text] [Related]
20. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
